Skip to main content
. 2014 Oct 14;124(25):3817–3827. doi: 10.1182/blood-2014-07-587477

Figure 1.

Figure 1

GVHD, NRM, and relapse. Cumulative incidences are shown for (A) aGVHD, (B) cGVHD, (C) NRM, (D) relapse for the entire cohort by disease type, (E) relapse for the entire cohort by donor type, and (F) relapse for AML patients by their pretransplantation remission status.